Autophagy Inhibition Sensitizes Liver Kinase B1 (LKB1)‐Deficient Kras‐Driven Lung Tumors to MEK Inhibitor Trametinib

Autor:	Vrushank Bhatt, Jessie Yanxiang Guo, Khoosheh Khayati, Jerry Kong, Akash Raju, Xiaoyang Su
Rok vydání:	2020
Předmět:	Trametinib Lung Kinase business.industry MEK inhibitor Autophagy medicine.disease_cause Biochemistry medicine.anatomical_structure Genetics Cancer research Medicine KRAS business Molecular Biology Biotechnology
Zdroj:	The FASEB Journal. 34:1-1
ISSN:	1530-6860 0892-6638
DOI:	10.1096/fasebj.2020.34.s1.05679
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ad68dbb4eab7d507dc42e09d4b11e7d8 https://doi.org/10.1096/fasebj.2020.34.s1.05679 Zobrazit plný text záznamu Plný text